Experimental basis for the clinical use of diphosphonates in paget's disease of bone
1980; Wiley; Volume: 23; Issue: 10 Linguagem: Inglês
10.1002/art.1780231014
ISSN1529-0131
Autores Tópico(s)Bone and Joint Diseases
ResumoArthritis & RheumatismVolume 23, Issue 10 p. 1162-1171 ArticleFree to Read Experimental basis for the clinical use of diphosphonates in paget's disease of bone Herbert Fleisch MD, Corresponding Author Herbert Fleisch MD Pathophysiology, University of Berne, Berne, Switzerland.University of Berne, Department of Pathophysiology, Murtenstrasse 35, 3010, Berne, SwitzerlandSearch for more papers by this author Herbert Fleisch MD, Corresponding Author Herbert Fleisch MD Pathophysiology, University of Berne, Berne, Switzerland.University of Berne, Department of Pathophysiology, Murtenstrasse 35, 3010, Berne, SwitzerlandSearch for more papers by this author First published: October 1980 https://doi.org/10.1002/art.1780231014Citations: 35AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Reference 1 Fleisch H, Neuman WF: Mechanisms of calcification: role of collagen, polyphosphates, and phosphatase. Am J Physiol 200: 1296–1300, 1961 CASPubMedWeb of Science®Google Scholar 2 Fleisch H, Russell RGG, Bisaz S, Termine JD, Posner AS: Influence of pyrophosphate on the transformation of amorphous to crystalline calcium phosphate. Calc Tiss Res 2: 49–59, 1968 10.1007/BF02279193 CASWeb of Science®Google Scholar 3 Hansen NM Jr, Felix R, Fleisch H: Aggregation of hydroxyapatite crystals. Biochim Biophys Acta 451: 549–559, 1976 10.1016/0304-4165(76)90150-1 CASPubMedWeb of Science®Google Scholar 4 Fleisch H, Maerki J, Russell RGG: Effect of pyrophosphate on dissolution of hydroxyapatite and its possible importance in calcium homeostasis. Proc Soc Exp Biol Med 122: 317–320, 1966 10.3181/00379727-122-31123 CASPubMedWeb of Science®Google Scholar 5 Jung A, Bisaz S, Fleisch H: The binding of pyrophosphate and two diphosphonates on hydroxyapatite crystals. Calc Tiss Res 11: 269–280, 1973 10.1007/BF02547227 CASPubMedWeb of Science®Google Scholar 6 Fleisch H, Straumann F, Schenk R, Bisaz S, Allgöwer M: Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture. Am J Physiol 211: 821–825, 1966 10.1152/ajplegacy.1966.211.3.821 CASPubMedWeb of Science®Google Scholar 7 Schibler D, Russell RGG, Fleisch H: Inhibition of pyrophosphate and polysphosphate of aortic calcification induced by vitamin D3 in rats. Clin Sci 35: 363–372, 1968 CASPubMedWeb of Science®Google Scholar 8 Gabbiani G: Effect of phosphates upon experimental skin calcinosis. Can J Physiol Pharmacol 44: 203–207, 1966 10.1139/y66-024 CASPubMedWeb of Science®Google Scholar 9 Schibler D, Fleisch H: Inhibition of skin calcification (calciphylaxis) by polyphosphates. Experientia 22: 367, 1966 10.1007/BF01901138 CASPubMedWeb of Science®Google Scholar 10 Russell RGG, Mühlbauer RC, Bisaz S, Williams DA, Fleisch H: The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised rats. Calc Tiss Res 6: 183–196, 1970 10.1007/BF02196199 CASPubMedWeb of Science®Google Scholar 11 Russell RGG, Bisaz S, Donath A, Morgan DB, Fleisch H. Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta and other disorders of bone. J Clin Invest 50: 961–969, 1971 10.1172/JCI106589 CASPubMedWeb of Science®Google Scholar 12 Fleisch H, Bisaz S: Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol 203: 671–675, 1962 10.1152/ajplegacy.1962.203.4.671 CASPubMedWeb of Science®Google Scholar 13 Hausmann E, Bisaz S, Russell RGG, Fleisch H: The concentration of inorganic pyrophosphate in human saliva and dental calculus. Arch Oral Biol 15: 1389–1392, 1970 10.1016/0003-9969(70)90029-4 CASPubMedGoogle Scholar 14 Russell RGG, Bisaz S, Fleisch H, Currey HLF, Rubinstein HM, Dietz AA, Boussine I, Gabay R, Micheli A, Fallet G: Inorganic pyrophosphate in the plasma, urine and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout). The Lancet ii: 899–902, 1970 10.1016/S0140-6736(70)92070-2 Google Scholar 15 McCarty DJ, Solomon SD, Warnock ML, Paloyan E: Inorganic pyrophosphate concentrations in the synovial fluid of arthritic patients. J Lab Clin Med 78: 216–229, 1971 CASPubMedWeb of Science®Google Scholar 16 Fleisch H, Russell RGG, Straumann F: Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212: 901–903, 1966 10.1038/212901a0 CASPubMedWeb of Science®Google Scholar 17 Fleisch H, Russell RGG: Experimental and clinical studies with pyrophosphate and diphosphonates, Calcium Metabolism in Renal Failure and Nephrolithiasis. Edited by DS David. New York. John Wiley & Sons Inc, 1977, pp 293–336 Google Scholar 18 Fleisch H, Russell RGG, Bisaz S, Mühlbauer RC, Williams DA: The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest 1: 12–18, 1970 10.1111/j.1365-2362.1970.tb00591.x CASPubMedWeb of Science®Google Scholar 19 Francis MD: The inhibition of calcium hydroxyapatite crystal growth by polyphosphates. Calc Tiss Res 3: 151–162, 1969 10.1007/BF02058658 CASPubMedWeb of Science®Google Scholar 20 Francis MD, Russell RGG, Fleisch H: Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science 165: 1264–1266, 1969 10.1126/science.165.3899.1264 CASPubMedWeb of Science®Google Scholar 21 Fleisch H, Russell RGG, Francis MD: Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 165: 1262–1264, 1969 10.1126/science.165.3899.1262 CASPubMedWeb of Science®Google Scholar 22 Fraser D, Russell RGG, Pohler O, Robertson WG, Fleisch H: The influence of disodium ethane-l-hydroxy-l, l-diphosphonate (EHDP) on the development of experimentally induced urinary stones in rats. Clin Sci 42: 197–207, 1972 10.1042/cs0420197 CASPubMedWeb of Science®Google Scholar 23 Meyer JL, Lee KE, Bergert JH: The inhibition of calcium oxalate crystal growth by multidentate organic phosphonates. Calc Tiss Res 23: 83–86, 1977 10.1007/BF02012770 CASPubMedWeb of Science®Google Scholar 24 Robertson WG, Peacock M, Nordin BEC: Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 43: 31–37, 1973 10.1016/0009-8981(73)90114-9 CASPubMedWeb of Science®Google Scholar 25 Felix R, Monod A, Broge L, Hansen NM, Fleisch H: Aggregation of calcium oxalate crystals: effect of urine and various inhibitors. Urol Res 5: 21–28, 1977 10.1007/BF00257112 CASPubMedWeb of Science®Google Scholar 26 Bisaz S, Felix R, Hansen NM, Fleisch H: Disaggregation of hydroxyapatite crystals. Biochim Biophys Acta 451: 560–566, 1976 10.1016/0304-4165(76)90151-3 CASPubMedWeb of Science®Google Scholar 27 Robertson WG, Morgan DB, Fleisch H, Francis MD: The effects of diphosphonates on the exchangeable and nonexchangeable calcium and phosphate of hydroxyapatite. Biochim Biophys Acta 261: 517–525, 1972 10.1016/0304-4165(72)90076-1 CASPubMedWeb of Science®Google Scholar 28 Grabenstetter RJ, Cilley WA: Polynuclear complex formation in solutions of calcium ion and ethane-l-hydroxy-l,l-diphosphonic acid. I. Complexometric and pH titrations. J Phys Chem 75: 676–682, 1971 10.1021/j100675a012 Web of Science®Google Scholar 29 Fleisch H: Physicochemical and biological effects of pyrophosphate and diphosphonates, Physico-chimie et Cristallographie des Apatites d'Intérét Biologique. Editions du Centre National de la Recherche Scientifique, Paris, 1975, pp 263–273 Google Scholar 30 Potokar M, Schmidt-Dunker M: The inhibitory effect of new diphosphonic acids on aortic and kidney calcification in vivo. Atherosclerosis 30: 313–320, 1978 10.1016/0021-9150(78)90124-7 CASPubMedWeb of Science®Google Scholar 31 Casey PA, Casey G, Fleisch H, Russell RGG: The effect of polyphloretin phosphate, polyoestradiol phosphate, a diphosphonate and a polyphosphate on calcification induced by dihydrotachysterol in skin, aorta and kidney of rats. Experientia 28: 137–138, 1972 10.1007/BF01935714 CASPubMedWeb of Science®Google Scholar 32 Rosenblum IY, Black HE, Ferrell JF: The effects of various diphosphonates on a rat model of cardiac calciphylaxis. Calc Tiss Res 23: 151–159, 1977 10.1007/BF02012781 CASPubMedWeb of Science®Google Scholar 33 Rayssiguier Y, Larvor P, Barlet JP: Etude de l'influence d'un phosphonate de sodium sur le taux rénal de calcium chez le rat carencé en magnésium. C R Acad Sci Paris 276: 2035–2038, 1973 CASPubMedWeb of Science®Google Scholar 34 Russell JE, Termine JD, Avioli LV: Experimental renal osteodystrophy: the response to 25-hydroxy-cholecalciferol and dichloromethylene diphosphate therapy. J Clin Invest 56: 548–554, 1975 10.1172/JCI108123 CASPubMedWeb of Science®Google Scholar 35 Francis MD, Flora LF, King WF: The effects of disodim ethane-l-hydroxy-l,l-diphosphonate on adjuvant induced arthritis in rats. Calc Tiss Res 9: 109–121, 1972 10.1007/BF02061949 CASPubMedWeb of Science®Google Scholar 36 Hollander W, McCombs HL, Franzblau C, Kirkpatrick B, Schmid K: Influence of the anti-calcifying agent, ethane-l-hydroxy-l, l-diphosphonate (EHDP) on pre-established atheromata in rabbits. Circulation (suppl III) 49: 50: 93, 1974 Google Scholar 37 Rosenblum IY, Flora L, Eisenstein R: The effect of disodum ethane-l-hydroxy-l,l-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis. Atherosclerosis 22: 411–424, 1975 10.1016/0021-9150(75)90021-0 CASPubMedWeb of Science®Google Scholar 38 Kramsch DM, Chan CT: The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous fatty plaques in rabbits. Circ Res 42: 562–571, 1978 10.1161/01.RES.42.4.562 CASPubMedWeb of Science®Google Scholar 39 Hollander W, Prusty S, Nagraj S, Kirkpatrick B, Paddock J, Colombo M: Comparative effects of cetaben (PHB) and dichloromethylene diphosphonate (Cl2MDP) on the development of atherosclerosis in the cynomolgus monkey. Atherosclerosis 31: 307–325, 1978 10.1016/0021-9150(78)90066-7 CASPubMedWeb of Science®Google Scholar 40 Briner WW, Francis MD, Widder, JS: The control of dental calculus in experimental animals. Int Dent J 21: 61–73, 1971 PubMedGoogle Scholar 41 Mühlemann HR, Bowles D, Schatt A, Bernimoulin JP: Effect of diphosphonate on human supragingival calculus. Helv Odont Acta 14: 31–33, 1970 PubMedWeb of Science®Google Scholar 42 Jowsey J, Holley KE, Linman JW: Effect of sodium etidronate in adult cats. J Lab Clin Med 76: 126–133, 1970 CASPubMedWeb of Science®Google Scholar 43 King WR, Francis MD, Michael WR: Effect of disodium ethane-l-hydroxy-l,l-diphosphonate on bone formation. Clin Orthop Rel Res 78: 251–270, 1971 10.1097/00003086-197107000-00021 CASPubMedGoogle Scholar 44 Russell RGG, Kislig AM, Casey PA, Fleisch H, Thornton J, Schenk R, Williams DA: Effect of diphosphonates on calcitonin on the chemistry and quantitative histology of rat bone. Calc Tiss Res 11: 179–195, 1973 10.1007/BF02547218 CASPubMedWeb of Science®Google Scholar 45 Schenk R, Merz WA, Mühlbauer R, Russell RGG, Fleisch H: Effect of ethane-l-hydroxy-l,l-diphosphonates (EHDP) and dichloromethylene diphosphonate (Cl2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calc Tiss Res 11: 196–214, 1973 10.1007/BF02547219 CASPubMedWeb of Science®Google Scholar 46 Rosenblum IY: The effects of disodium ethane-l-hydroxy-l,l-diphosphonate (EHDP) on bone and serum chemistry in rabbits. Calc Tiss Res 16: 145–152, 1974 10.1007/BF02008220 CASPubMedWeb of Science®Google Scholar 47 Larsson A, Larsson SE: Light microscopic and ultrastructural observations on the short term effects of ethylene-l-hydroxy-l,l-diphosphonate (EHDP) on rat tibia epiphysis. Acta Path Microbiol Scand 84: 17–27, 1976 CASPubMedWeb of Science®Google Scholar 48 Bisaz S, Schenk R, Kunin AS, Russell RGG, Mühlbauer R, Fleisch H: The comparative effects of vitamin D deficiency and ethane-l-hydroxy-l,l-diphosphonate administration on the histology and glycolysis of chick epiphyseal and articular cartilage. Calc Tiss Res 19: 139–152, 1975 10.1007/BF02563998 CASPubMedWeb of Science®Google Scholar 49 Trechsel U, Schenk R, Bonjour JP, Russell RGG, Fleisch H: Relation between bone mineralization, Ca absorption, and plasma Ca in phosphonate-treated rats. Am J Physiol 232: E298–E305, 1977 10.1152/ajpendo.1977.232.3.E298 CASPubMedWeb of Science®Google Scholar 50 Larsson SE: The metabolic heterogeneity of glycosaminoglycans of the different zones of the epiphyseal growth plate and the effect of ethane-l-hydroxy-l,l-diphosphonate (EHDP) upon glycosaminoglycan synthesis in vivo. Calc Tiss Res 21: 67–82, 1976 10.1007/BF02547384 CASPubMedWeb of Science®Google Scholar 51 Howell DS, Pita JC: Role of protoglycans in calcification of cartilage. Upsala J Med Sci 82: 97–98, 1977 10.3109/03009737709179080 CASPubMedWeb of Science®Google Scholar 52 Larsson A, Larsson SE: The effects of ethane-l-hydroxy-l,l-diphosphonate on cellular transformation and organic matrix of the epiphyseal growth plate of the rat: a light microscopic and ultrastructural study. Acta Pathol Microbiol Scand 86: 211–223, 1978 CASPubMedWeb of Science®Google Scholar 53 Larsson A: The short-term effects of high doses of ethylene-l-hydroxy-l,l-diphosphonates upon early dentin formation. Calc Tiss Res 16: 109–127, 1974 10.1007/BF02008217 CASPubMedWeb of Science®Google Scholar 54 Reynolds JJ, Minkin C, Morgan DB, Spycher D, Fleisch H: The effect of two diphosphonates on the resorption of mouse calvaria in vitro. Calc Tiss Res 10: 302–313, 1972 10.1007/BF02012561 CASPubMedWeb of Science®Google Scholar 55 Hausmann E, Weinfeld N, Michaels S: Lipopolysaccharide-diphosphonate interaction on bone in tissue culture. Arch Oral Biol 17: 1381–1384, 1972 10.1016/0003-9969(72)90172-0 CASPubMedWeb of Science®Google Scholar 56 Gebauer U, Fleisch H: The effect of two diphosphonates on the resorption of mouse calvaria induced by lα,25-dihydroxycholecalciferol and prostaglandin E1 in culture. Min Electrol Metab, in press, 1980 Google Scholar 57 Minkin C, Rabadjija L, Goldhaber P: Bone remodelling in vitro: the effect of two diphosphonates in osteoid synthesis and bone resorption in mouse calvaria. Calc Tiss Res 14: 161–168, 1974 10.1007/BF02060292 CASPubMedWeb of Science®Google Scholar 58 Rowe DJ, Hausmann E: The alteration of osteoclast morphology by diphosphonate in bone organ culture. Calc Tiss Res 20: 53–60, 1976 10.1007/BF02546397 CASPubMedWeb of Science®Google Scholar 59 Shinoda H, Felix R, Fleisch H: Structure-activity relationship of diphosphonates with alkyl groups of various length. Min Electrol Metab 2: 268–269, 1979 Web of Science®Google Scholar 60 Reynolds JJ, Murphy H, Mühlbauer RC, Morgan DB, Fleisch H: Inhibition by diphosphonates of bone resorption in mice and comparison with grey lethal osteopetrosis. Calc Tiss Res 12: 59–71, 1973 10.1007/BF02013722 CASPubMedWeb of Science®Google Scholar 61 Gasser AB, Morgan DB, Fleisch HA, Richelle LJ: The influence of two diphosphonates on calcium metabolism in the rat. Clin Sci 43: 31–45, 1972 10.1042/cs0430031 CASPubMedWeb of Science®Google Scholar 62 Michael WR, King WR, Francis MD: Effectiveness of diphosphonates in preventing “osteoporosis” of disuse in the rat. Clin Orthop Rel Res 78: 271–276, 1971 10.1097/00003086-197107000-00022 PubMedGoogle Scholar 63 Mühlbauer RC, Russell RGG, Williams DA, Fleisch H: The effects of diphosphonates, polyphosphates, and calcitonin on “immobilisation osteoporosis” in rats. Eur J Clin Invest 1: 336–344, 1971 10.1111/j.1365-2362.1971.tb00640.x CASPubMedWeb of Science®Google Scholar 64 Goulding A, McChesney R: Comparison of effects of parathyroidectomy and ethane-l-hydroxy-l,l-diph-osphonate (EHDP) administration upon bone synthesis of hydroxyproline and urinary excretion of hydroxy-proline in rats. Calc Tiss Res 23: 115–119, 1977 10.1007/BF02012775 CASPubMedWeb of Science®Google Scholar 65 Yarrington JT, Capen CC, Black HE, Re R, Potts JT Jr, Geho WB: Experimental parturient hypocalcemia in cows following prepartal chemical inhibition of bone resorption. Am J Pathol 83: 569–587, 1976 CASPubMedWeb of Science®Google Scholar 66 Yarrington JT, Capen CC, Black HE, Re R, Nagode LA, Geho WB: Effect of dichloromethane diphosphonate on calcium homeostasis mechanisms in pregnant cows. Am J Pathol 87: 615–632, 1977 CASPubMedWeb of Science®Google Scholar 67 Bonjour JP, Fleisch H, Copp DH: Influence of a diphosphonate on serum calcium homeostasis. Proc Exp Biol Med 143: 404–407, 1973 10.3181/00379727-143-37331 CASPubMedWeb of Science®Google Scholar 68 Yarrington JT, Capen CC, Black HE, Re R, Potts JT Jr, Geho WB: Effect of ethane-l-hydroxy-l,l-diphosphonate (EHDP) on the ultrastructure of parathyroid glands and plasma immunoreactive parathyroid hormone in pregnant cows fed a low calcium diet. Lab Invest 36: 402–412, 1977 CASPubMedWeb of Science®Google Scholar 69 Lane JM, Steinberg ME: The role of diphosphonates in osteoporosis of disuse. J Trauma 13: 863–869, 1973 10.1097/00005373-197313100-00004 CASWeb of Science®Google Scholar 70 Cabanela ME, Jowsey J: The effects of phosphonates on experimental osteoporosis. Calc Tiss Res 8: 114–120, 1971 10.1007/BF02010128 CASPubMedWeb of Science®Google Scholar 71 Hähnel H, Mühlbach R, Lindenhayn K, Schaetz P, Schmidt UJ: Zum Einfluss von Diphosphonat auf die exprimentelle Heparinosteopathie. Z Alternsforsch 27: 289–292, 1973 CASPubMedGoogle Scholar 72 Hähnel H, Lindenhayn K, Mühlbach R, Schmidt UJ, Kalbe I: Antikoagulantienosteopathie durch Kumarin und deren Beeinfussung mit Diphosphonat: eine tierexperimentelle Studie. Dtsch Gesundheitswesen 31: 856–859, 1976 Google Scholar 73 Black HE, Jee WSS: A histomorphometric and biochemical evaluation of the effects of a diphosphonate in corti-costeroid-treated rabbits. Bone Histomorphometry. Edited by PJ Meunier. Paris, Lab Armour Montagu, 1977, pp 157–169 Web of Science®Google Scholar 74 Jowsey J, Holley KE: Influence of diphosphonates on progress of experimentally induced osteoporosis. J Lab Clin Med 82: 567–575, 1973 CASPubMedWeb of Science®Google Scholar 75 Morgan DB, Gasser A, Largiadér U, Jung A, Fleisch H: Effects of a diphosphonate on calcium metabolism in calcium-deprived rats. Am J Physiol 228: 1750–1756, 1975 CASPubMedWeb of Science®Google Scholar 76 Miller SC, Jee WSS: Ethane-l-hydroxy-l,l-diphosphonate (EHDP): Effects on growth and modeling of the rattibia. Calc Tiss Res 18: 215–231, 1975 10.1007/BF02546241 CASPubMedWeb of Science®Google Scholar 77 Miller SC, Jee WSS, Kimmel DB, Woodbury L: Ethane-l-hydroxy-l,l-diphosphonate (EHDP) effects on incorporation and accumulation of osteoclast nuclei. Calc Tiss Res 22: 243–252, 1977 10.1007/BF02010363 CASPubMedWeb of Science®Google Scholar 78 Pilczyk R, Sutcliffe H, Martin TJ: Effects of pyrophosphate and diphosphonates on parathyroid hormone- and fluoride-stimulated adenylate cyclase activity. FEBS Letters 24: 225–228, 1972 10.1016/0014-5793(72)80772-5 CASPubMedWeb of Science®Google Scholar 79 Eisman JA, Martin TJ, Pilczyk R, Legge DG, Sutcliffe HS: Influence of pyrophosphate and diphosphonates on rat liver adenylate cyclase. Clin Exp Pharmacol Physiol 1: 13–21, 1974 10.1111/j.1440-1681.1974.tb00522.x CASPubMedWeb of Science®Google Scholar 80 Goulding A, McChesney R, Malthus RS: Diminished urinary excretion of cyclic AMP by rats given disodium ethane-l-hydroxy-l,l-diphosphonate. J Endocrinol 65: 145–146, 1975 10.1677/joe.0.0650145 CASPubMedWeb of Science®Google Scholar 81 Gebauer U, Russell RGG, Touabi M, Fleisch H: Effect of diphosphonates on adenosine 3': 5' cyclic monosphosphate in mouse calvaria after stimulation by parathyroid hormone in vitro. Clin Sci Mol Med 50: 473–478, 1976 CASPubMedWeb of Science®Google Scholar 82 Felix R, Russell RGG, Fleisch H: The effect of several diphosphonates on acid phosphohydrolases and other lysosomal enzymes. Biochim Biophys Acta 429: 429–438, 1976 10.1016/0005-2744(76)90291-6 CASPubMedWeb of Science®Google Scholar 83 Morgan DB, Monod A, Russell RGG, Fleisch H: Influence of dichloromethylene diphosphonate (Cl2MDP) and calcitonin on bone resorption, lactate production and phosphatase and pyrophosphatase content of mouse calvaria treated with parathyroid hormone in vitro. Calc Tiss Res 13: 287–294, 1973 10.1007/BF02015418 CASPubMedWeb of Science®Google Scholar 84 Doty SB, Jones R, Finerman GA: Diphosphonte influence on bone cell structure and lysosomal activity. J Bone Joint Surg 54: 1128–1129, 1972 Web of Science®Google Scholar 85 Ende JJ: Effects of some diphosphonates on the metabolism of bone in vivo and in vitro. Leiden, Thesis, 1979 Google Scholar 86 Guilland DF, Sallis JD, Fleisch H: The effect of two diphosphonates on the handling of calcium by rat kidney mitochondria in vitro. Calc Tiss Res 15: 303–314, 1974 10.1007/BF02059065 CASPubMedWeb of Science®Google Scholar 87 Guilland DF, Fleisch H: The effect of in vivo treatment with EHDP and/or 1,25-DHCC on calcium uptake and release in isolated kidney mitochondria. Biochem Biophys Res Commun 61: 906–911, 1974 10.1016/0006-291X(74)90241-1 CASPubMedWeb of Science®Google Scholar 88 Fast DK, Felix R, Dowse C, Neuman WF, Fleisch H: The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture. Biochem J 172: 97–197, 1978 10.1042/bj1720097 CASPubMedWeb of Science®Google Scholar 89 Lemkes HHPJ: A.P.D.–a new diphosphonate: its influence on bone metabolism in the rat. Thesis, 1978 Google Scholar 90 Felix R, Fleisch H: Effect of EHDP and Cl2MDP on the metabolism of glucose and fatty acids in cultured calvaria cells. Min Electrol Metab 2: 223–224, 1979 Web of Science®Google Scholar 91 Felix R, Fleisch H: Increase in alkaline phosphatase activity in calvaria cells cultured with diphosphonates. Biochem J 183: 73–81, 1979 10.1042/bj1830073 CASPubMedWeb of Science®Google Scholar 92 Weisbrode SE, Capen CC, Pendley CB: Effect of dichloromethylene diphosphonate on morphology, enzyme activity, and ash content of bones of thyropara-thyroidectomized rats. Calc Tiss Res 25: 119–126, 1978 10.1007/BF02010760 CASPubMedWeb of Science®Google Scholar 93 Guenther HL, Guenther HE, Fast DK, Fleisch H: The effect of two diphosphonates on the collagen metabolism of mouse and rat bone and cartilage. Experientia 3: 792, 1977 Google Scholar 94 Guenther HL, Guenther HE, Fleisch H: Effects of l-hydroxyethane-l,l-diphosphonate and dichloromethanedi-phosphonate on rabbit articular chondrocytes in culture. Biochem J 184: 203–214, 1979 10.1042/bj1840203 CASPubMedWeb of Science®Google Scholar 95 Felix R, Fast DK, Sallis JD, Fleisch H: Effect of diphosphonates on glycogen content of rabbit ear cartilage cells in culture. Calc Tiss Int, in press Google Scholar 96 Bisaz S, Jung A, Fleisch H: Uptake by bone of pyro-phosphate, diphosphonates and their technetium derivatives. Clin Sci Mol Med 54: 265–272, 1978 CASPubMedWeb of Science®Google Scholar 97 Bonjour JP, Russell RGG, Morgan DB, Fleisch HA: Intestinal calcium absorption, Ca-binding protein, and Ca-ATPase in diphosphonate-treated rats. Am J Physiol 224: 1011–1017, 1973 CASWeb of Science®Google Scholar 98 Bonjour JP, DeLuca HF, Fleisch H, Trechsel U, Matejowec LA, Omdahl JL: Reversal of the EHDP inhibition of calcium absorption by 1,25-dihydroxycholecalciferol. Eur J Clin Invest 3: 44–48, 1973 10.1111/j.1365-2362.1973.tb00328.x CASPubMedWeb of Science®Google Scholar 99 Baxter LA, DeLuca HF, Bonjour JP, Fleisch H: Inhibition of vitamin D metabolism by ethane-l-hydroxy-l,l-diphosphonate. Arch Biochem Biophys 164: 655–662, 1974 10.1016/0003-9861(74)90077-0 CASPubMedWeb of Science®Google Scholar 100 Hill LF, Lumb GA, Mawer EB, Stanbury SW: Indirect inhibition of the biosynthesis of 1,25-dihydroxycholecalciferol in rats treated with a diphosphonate. Clin Sci 44: 335–347. 1973 10.1042/cs0440335 CASPubMedWeb of Science®Google Scholar 101 Trechsel U, Bonjour JP, Fleisch H: Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells. J Clin Invest 64: 206–217, 1979 10.1172/JCI109441 CASPubMedWeb of Science®Google Scholar 102 Bonjour JP, Trechsel U, Fleisch H, Schenk R, DeLuca HF, Baxter LA: Action of 1,25-dihydroxyvitamin D3 and a diphosphonate on calcium metabolism in rats. Am J Physiol 229: 402–408, 1975 CASPubMedWeb of Science®Google Scholar 103 Nicolaysen R: The absorption of calcium as a function of the body saturation with calcium. Acta Physiol Scand 5: 200–211, 1943 10.1111/j.1748-1716.1943.tb02047.x CASGoogle Scholar 104 Guilland D, Trechsel U, Bonjour JP, Fleisch H: Stimulation of calcium absorption and apparent increased intestinal 1,25-dihydroxycholecalciferol in rats treated with low doses of ethane-l-hydroxy-l,l-diphosphonate. Clin Sci Mol Med 48: 157–160, 1975 CASPubMedWeb of Science®Google Scholar 105 Bonjour JP, Troehler U, Preston C, Fleisch H: Parathyroid hormone and renal handling of Pi: effect of dietary Pi and diphosphonates. Am J Physiol 234: F487–F505, 1978 Google Scholar 106 Tröhler U, Bonjour JP, Fleisch H: Inorganic phosphate homeostasis: renal adaptation to the dietary intake in intact and thyroparathyroidectomized rats. J Clin Invest 57: 164–173, 1976 10.1172/JCI108277 Web of Science®Google Scholar 107 Recker RR, Hassing GS, Lau JR, Saville PD: The hyperphosphatemic effect of disodium ethane-l-hydroxy-l,l-diphosphonates (EHDP(TM)): renal handling of phosphorus and the renal response to parathyroid hormone. J Lab Clin Med 81: 258–266, 1973 CASPubMedWeb of Science®Google Scholar 108 Komissarenko SV, Zhuravskii NI, Karlova NP, Gulyi MF: Inhibition of hypersensitivity of delayed and immediate types in guinea pigs by methylenediphosphonic acid. Byull Eksp Biol Med 84: 1322–1323, 1977 10.1007/BF00805896 Web of Science®Google Scholar 109 Flora L: Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis. Arthritis Rheum 22: 340–346, 1979 10.1002/art.1780220405 CASPubMedWeb of Science®Google Scholar 110 Michael WR, King WR, Wakim JM: Metabolism of disodium ethane-l-hydroxy-l,l-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey. Toxic Appl Pharmacol 21: 503–515, 1972 10.1016/0041-008X(72)90007-5 CASPubMedWeb of Science®Google Scholar 111 Recker RR, Saville PD: Intestinal absorption of disodium ethane-l-hydroxy-l,l-diphosphonate (disodium etidronate) using a deconvolution technique. Toxic Appl Pharmacol 24: 580–589, 1973 10.1016/0041-008X(73)90219-6 CASPubMedWeb of Science®Google Scholar 112 Anbar M, Newell GW, St John GA: Fate and toxicity of orally administered polyethylene polyphosphonates. Fed Cosmet Toxicol 11: 1001–1010, 1973 CASPubMedWeb of Science®Google Scholar 113 Wasserman RH, Bonjour JP, Fleisch H: Heal absorption of disodium ethane-l-hyodrxy-l,l-diphosphonate (EHDP) and disodium dichloromethylene diphosphonate (Cl2MDP) in the chick. Experientia 29: 1110–1111, 1973 10.1007/BF01946749 CASPubMedWeb of Science®Google Scholar 114 Troehler U, Bonjour JP, Fleisch H: Renal secretion of diphosphonates in rats. Kidney Int 8: 6–13, 1975 10.1038/ki.1975.70 CASPubMedWeb of Science®Google Scholar Citing Literature Volume23, Issue10October 1980Pages 1162-1171 ReferencesRelatedInformation
Referência(s)